John A. T. Young

15.5k citations

123 papers · 9.7k indexed · 4 hit papers · h-index 49

Impact in

Virology top 0.2%
- HIV Research and Treatment
Genetics top 0.5%
- Bacterial Genetics and Biotechnology
- Virus-based gene therapy research

Papers in

Virology 29
- HIV Research and Treatment 26
Hepatology 13
- Hepatitis C virus research 13

Co-authors: R. John Collier Alan D. Frankel Kenneth A. Bradley Heather M. Scobie Richard J. O. Barnard G. Jonah Rainey Paul Bates Harold Varmus
Journals: Journal of Virology (23 papers)Proceedings of the National Academy of Sciences (12 papers)PLoS Pathogens (8 papers)PLoS ONE (7 papers)Virology (5 papers)
Partner nations: United States Switzerland United Kingdom

In The Last Decade

John A. T. Young

122 papers receiving 9.4k citations

Hit Papers

align trajectories log scale

Monosynaptic Restriction of Transsynaptic Tracing from Single, Genetically Targeted Neurons 2007 · 867 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2007 Neuron
2003 Proceedings of the National Academy of Sciences
2001 Nature
1998 Annual Review of Biochemistry

Peers

Replace John H. Elder with:

John H. Elder United States

Hildegund C.J. Ertl United States

George N. Pavlakis United States

R. Mark L. Buller United States

Donald M. Coen United States

John K. Rose United States

Daniel J. Capon United States

Philip J. Barr United States

David Kabat United States

Mark Marsh United Kingdom

John A. T. Young relative to John H. Elder United States John H. Elder's profile →

Citations per field

00.5×2×2.7×

John H. Elder · 1×

×0.6 2k/4k

VIROL

×1.0 3k/3k

GENET

×2.1 807/387

BIOTE

×0.9 2k/2k

IMMUN

×0.8 2k/2k

ID

Citations per year

2016

2017

2018

2019

2020

2021

2022

2023

2024

2025

2026

Countries citing papers authored by John A. T. Young

Since Specialization

Citations

This map shows the geographic impact of John A. T. Young's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John A. T. Young with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John A. T. Young more than expected).

Fields of papers citing papers by John A. T. Young

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John A. T. Young. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John A. T. Young. The network helps show where John A. T. Young may publish in the future.

Co-authors

The 25 scholars most cited alongside John A. T. Young, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with John A. T. Young Line = papers co-authored together John A. T. Young links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Toll-Like Receptor 7 Agonist RG7854 Mediates Therapeutic Efficacy and Seroconversion in Woodchucks With Chronic Hepatitis B Frontiers in Immunology ·Steffen Wildum, Kyle Korolowicz, Manasa Suresh, Guido Steiner, Lue Dai, Bin Li, Changsuek Yon, Maria Cristina De Vera Mudry, Franziska Regenass-Lechner, Xu Huang, Xupeng Hong, Marta G. Murreddu, Bhaskar Kallakury, John A. T. Young, Stephan Menne	2022	6
2	Accelerated Preclinical Paths to Support Rapid Development of COVID-19 Therapeutics Cell Host & Microbe ·Jay A. Grobler, Annaliesa S. Anderson, Prabhavathi Fernandes, Michael Diamond, Christine M. Colvis, Joseph P. Menetski, Rosa Álvarez, John A. T. Young, Kara Carter	2020	25
3	HBVcircle: A novel tool to investigate hepatitis B virus covalently closed circular DNA Journal of Hepatology ·Zhipeng Yan, Jing Zeng, Youjun Yu, Kunlun Xiang, Hui Hu, Xue Zhou, Lili Gu, Li Wang, Jie Zhao, John A. T. Young, Lu Gao	2017	62
4	An Integrated Map of HIV-Human Protein Complexes that Facilitate Viral Infection PLoS ONE ·Dorothea Emig-Agius, Kevin C. Olivieri, Lars Pache, Hsin Ling Shih, Olga Pustovalova, Marina Bessarabova, John A. T. Young, Sumit K. Chanda, Trey Ideker	2014	11
5	CHD1 and CHD2 are positive regulators of HIV-1 gene expression Virology Journal ·Melissa J Rodgers, David J. Banks, Kenneth A. Bradley, John A. T. Young	2014	11
6	ZASC1 Stimulates HIV-1 Transcription Elongation by Recruiting P-TEFb and TAT to the LTR Promoter PLoS Pathogens ·James W. Bruce, Rachel Reddington, Elizabeth Mathieu, Megan Bracken, John A. T. Young, Paul Ahlquist	2013	14
7	Anthrax toxin receptor 2 is expressed in murine and tumor vasculature and functions in endothelial proliferation and morphogenesis Oncogene ·Claire Reeves, Joseph Dufraine, John A. T. Young, Jan Kitajewski	2009	57
8	A Viral Nanoparticle with Dual Function as an Anthrax Antitoxin and Vaccine PLoS Pathogens ·Darly J. Manayani, Diane Thomas, Kelly A. Dryden, Vijay Reddy, Marc E Siladi, John Marlett, G. Jonah Rainey, Michael E. Pique, Heather M. Scobie, Mark Yeager, John A. T. Young, Marianne Manchester, Anette Schneemann	2007	69
9	Anthrax Toxin Receptor 2 Determinants that Dictate the pH Threshold of Toxin Pore Formation PLoS ONE ·Heather M. Scobie, John Marlett, G. Jonah Rainey, D. Borden Lacy, R. John Collier, John A. T. Young	2007	35
10	Receptor-specific requirements for anthrax toxin delivery into cells Proceedings of the National Academy of Sciences ·G. Jonah Rainey, Darran J. Wigelsworth, Patricia L. Ryan, Heather M. Scobie, R. John Collier, John A. T. Young	2005	107
11	Interactions between anthrax toxin receptors and protective antigen Current Opinion in Microbiology ·Heather M. Scobie, John A. T. Young	2005	84
12	Clinical management. Where medicine meets management. Senior moments. PubMed ·John A. T. Young, Deborah Sturdy	2004	1
13	Amino acid residues Tyr-67, Asn-72, and Asp-73 of the TVB receptor are important for subgroup E avian sarcoma and leukosis virus interaction Virology ·Sara Klucking, John A. T. Young	2004	20
14	Human capillary morphogenesis protein 2 functions as an anthrax toxin receptor Proceedings of the National Academy of Sciences ·Heather M. Scobie, G. Jonah Rainey, Kenneth A. Bradley, John A. T. Young Hit paper breakdown →	2003	502
15	Allelic variation in the hemolymph juvenile hormone binding protein gene of Manduca sexta Molecular and Cellular Endocrinology ·John A. T. Young	2003	4
16	Attacking Anthrax Scientific American ·John A. T. Young, John R Collier	2002	12
17	Annihilating Infectious Diseases Cell ·John A. T. Young	2000	1
18	CAR1, a TNFR–Related Protein, Is a Cellular Receptor for Cytopathic Avian Leukosis–Sarcoma Viruses and Mediates Apoptosis Cell ·Jürgen Brojatsch, John Naughton, Melissa M. Rolls, K Zingler, John A. T. Young	1996	217
19	TheHLA-DNA (DZA) gene is correctly expressed as a 1.1 kb mature mRNA transcript Immunogenetics ·John A. T. Young, John Trowsdale	1990	16
20	Epitope recognition by a DPα chain-specific monoclonal antibody (DP11.1) is influenced by the interaction between the DPα chain and its polymorphic DPβ chain partner Human Immunology ·John A. T. Young, J. Lindsay, Julia G. Bodmer, John Trowsdale	1988	11

About John A. T. Young

John A. T. Young is a scholar working on Virology, Hepatology, Biotechnology, Immunology and Epidemiology, having authored 123 papers that have together received 9.7k indexed citations. Recurring topics across this work include Herpesvirus Infections and Treatments (30 papers), Bacillus and Francisella bacterial research (26 papers), HIV Research and Treatment (26 papers), Bacterial Genetics and Biotechnology (17 papers), Virus-based gene therapy research (15 papers), Hepatitis B Virus Studies (14 papers), Hepatitis C virus research (13 papers) and Microbial Inactivation Methods (13 papers). The work is most often cited by research in Virology (2.1k citations), Genetics (2.7k citations), Biotechnology (807 citations), Immunology (2.0k citations) and Infectious Diseases (1.6k citations). John A. T. Young has collaborated with scholars based in United States, Switzerland and United Kingdom. Frequent co-authors include R. John Collier, Alan D. Frankel, Kenneth A. Bradley, Heather M. Scobie, Richard J. O. Barnard, G. Jonah Rainey, Paul Bates, Harold Varmus, Jeremy Mogridge and Michaël Mourez. Their work appears in journals such as Journal of Virology, Proceedings of the National Academy of Sciences, PLoS Pathogens, PLoS ONE and Virology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact